The assay that we are discussing here is called PUBCHEM_BIOASSAY: Fluorescence polarization. It is being used to screen for inhibitors that can possibly disrupt the protein-protein interaction between Keap1 and Nrf2. This screening process is being carried out in a Biochemical System with the help of a Plate Reader. The specific activity the screening process focuses on is called 2119-01_Inhibitor_Dose_CherryPick_Activity. This particular assay is classed as a confirmatory assay and implies that multiple homologous protein targets may be assigned for screening. Further, it is important to note that the assay category is confirmatory, which means that this assay is being used to confirm the activity of a specific chemical treatment. The assay type description is Binding, which means that it is being used to find out whether there is a binding between two specified proteins in a specific environment. Additionally, it is worth noting that this assay is closely related to another PUBCHEM assay, namely AID504540, which is defined by the depositor. Does this molecule work well for this assay?